CD8A and common variable immunodeficiency: Cluster 3 (1 patient with Good’s syndrome and 3 CVID patients) and cluster 4 (8 CVID patients) were characterized by an increase of HLA-DR + activation, terminal effector CD8+ T cells and immunosenescence marker (Table 3).